학술논문
Health-related quality of life impact from adding bevacizumab to cisplatin-pemetrexed in malignant pleural mesothelioma in the MAPS IFCTGFPC-0701 phase III trial
Document Type
Article
Author
Source
In: Clinical Cancer Research . (Clinical Cancer Research, 1 October 2019, 25(19):5759-5765)
Subject
Language
English
ISSN
15573265
10780432
10780432